IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,341 | -34.7% | 13,042 | +1.0% | 0.00% | – |
| Q2 2023 | $90,936 | +45.7% | 12,917 | +26.4% | 0.00% | – |
| Q1 2023 | $62,426 | -67.1% | 10,217 | -48.6% | 0.00% | – |
| Q3 2022 | $190,000 | -13.2% | 19,863 | +0.3% | 0.00% | – |
| Q2 2022 | $219,000 | -14.5% | 19,813 | +28.8% | 0.00% | – |
| Q1 2022 | $256,000 | +33.3% | 15,386 | +53.3% | 0.00% | – |
| Q4 2021 | $192,000 | -5.4% | 10,036 | +21.8% | 0.00% | – |
| Q3 2021 | $203,000 | -54.0% | 8,239 | -51.4% | 0.00% | – |
| Q2 2021 | $441,000 | -28.4% | 16,965 | -12.8% | 0.00% | -100.0% |
| Q1 2021 | $616,000 | -37.7% | 19,445 | -8.7% | 0.00% | 0.0% |
| Q4 2020 | $988,000 | -36.7% | 21,298 | -55.1% | 0.00% | -50.0% |
| Q3 2020 | $1,562,000 | +39.1% | 47,449 | +15.9% | 0.00% | 0.0% |
| Q2 2020 | $1,123,000 | -16.1% | 40,928 | -28.0% | 0.00% | 0.0% |
| Q1 2020 | $1,339,000 | +258.0% | 56,878 | +320.6% | 0.00% | – |
| Q4 2019 | $374,000 | +41.7% | 13,524 | -6.8% | 0.00% | – |
| Q3 2019 | $264,000 | -42.7% | 14,512 | -22.8% | 0.00% | -100.0% |
| Q2 2019 | $461,000 | -31.9% | 18,793 | -64.4% | 0.00% | 0.0% |
| Q2 2018 | $677,000 | -22.9% | 52,856 | +1.7% | 0.00% | -50.0% |
| Q1 2018 | $878,000 | – | 51,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |